For the year ending 2025-12-31, MDCX has $10,061,377 in assets. $10,024,066 in debts. $8,705,218 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents, end of year | 8,705,218 | |||
| Prepaid expense, current | 1,086,121 | |||
| Deferred financing costs | 99,305 | |||
| Total current assets | 9,890,644 | |||
| Operating lease, right-of-use asset | 170,733 | |||
| Assets | 10,061,377 | |||
| Accounts payable, current | 3,435,297 | |||
| Accrued and other accounts payable | 995,290 | |||
| Represents the related party payable | 116,476 | |||
| Operating lease, liability, current | 145,456 | |||
| Ending balance | 5,245,543 | |||
| Liabilities, current | 9,938,062 | |||
| Loans payable, noncurrent | 25,865 | |||
| Operating lease, liability, noncurrent | 60,139 | |||
| Total liabilities | 10,024,066 | |||
| Common stock, value, issued | 57,076,175 | |||
| Represents the amount of common shares to be issued | 313,934 | |||
| Additional paid-in capital | 6,879,575 | |||
| Accumulated other comprehensive income (loss), net of tax | 10,880 | |||
| Accumulated deficit | -64,348,118 | |||
| Equity, attributable to parent | -67,554 | |||
| Equity, attributable to noncontrolling interest | 104,865 | |||
| Ending balance | 37,311 | |||
| Total liabilities and shareholders' deficit | 10,061,377 | |||
Medicus Pharma Ltd. (MDCX)
Medicus Pharma Ltd. (MDCX)